CA2373855A1 - Methode de traitement de troubles psychotiques - Google Patents

Methode de traitement de troubles psychotiques Download PDF

Info

Publication number
CA2373855A1
CA2373855A1 CA002373855A CA2373855A CA2373855A1 CA 2373855 A1 CA2373855 A1 CA 2373855A1 CA 002373855 A CA002373855 A CA 002373855A CA 2373855 A CA2373855 A CA 2373855A CA 2373855 A1 CA2373855 A1 CA 2373855A1
Authority
CA
Canada
Prior art keywords
formula
compounds
base
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002373855A
Other languages
English (en)
Inventor
Roelof Van Hes
Johannes A. M. Van Der Heijden
Cornelis G. Kruse
Stephen K. Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2373855A1 publication Critical patent/CA2373855A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne l'utilisation de composés présentant à la fois une activité antagoniste à la dopamine D2 et une activité inhibant le recaptage de la sérotonine (IRS) dans le traitement de troubles psychotiques tels que la schizophrénie. L'invention concerne également un groupe de nouveaux dérivés de (1,2,3,6-tétrahydropyridin-4-yl) indole et furane présentant ces activités.
CA002373855A 1999-05-12 2000-04-14 Methode de traitement de troubles psychotiques Abandoned CA2373855A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99201524.8 1999-05-12
EP99201524 1999-05-12
PCT/EP2000/003506 WO2000069424A2 (fr) 1999-05-12 2000-04-14 Methode de traitement de troubles psychotiques

Publications (1)

Publication Number Publication Date
CA2373855A1 true CA2373855A1 (fr) 2000-11-23

Family

ID=8240207

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002373855A Abandoned CA2373855A1 (fr) 1999-05-12 2000-04-14 Methode de traitement de troubles psychotiques

Country Status (5)

Country Link
EP (1) EP1200072A2 (fr)
JP (1) JP2002544223A (fr)
AU (1) AU4552200A (fr)
CA (1) CA2373855A1 (fr)
WO (1) WO2000069424A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028685A1 (es) * 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol
DE102004023506A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023635A1 (de) * 2004-05-10 2006-04-13 Grünenthal GmbH Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023508A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023522A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023501A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023507A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
DE102004023632A1 (de) * 2004-05-10 2005-12-08 Grünenthal GmbH Substituierte Cyclohexylcarbonsäure-Derivate
JP2008521771A (ja) * 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
MX2007006757A (es) * 2004-12-07 2007-11-09 Solvay Pharm Bv Tetrahidropiridin-4-il-indoles con una combinacion de afinidad para receptores de dopamina-d2 y sitios de reabsorcion de serotonina.
US20060122247A1 (en) 2004-12-08 2006-06-08 Solvay Pharmaceuticals B.V. Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
CA2091204C (fr) * 1992-03-11 1997-04-08 Ronald J. Mattson Piperazinyl- et piperidinylcyclohexanes contre l'ischemie
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
AR020773A1 (es) * 1998-10-16 2002-05-29 Duphar Int Res Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto

Also Published As

Publication number Publication date
WO2000069424A2 (fr) 2000-11-23
WO2000069424A3 (fr) 2001-06-07
AU4552200A (en) 2000-12-05
JP2002544223A (ja) 2002-12-24
EP1200072A2 (fr) 2002-05-02

Similar Documents

Publication Publication Date Title
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
US5760234A (en) Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
JP2722279B2 (ja) アミノメチレンで置換した非芳香族複素環式化合物及びサブスタンスｐのアンタゴニストとしての使用
US5585378A (en) Composition containing an oxoindole compound
IE58338B1 (en) Pyrimidinyl-piperazine derivatives
CA2652852A1 (fr) Derives d'urees de piperidine ou pyrrolidine, leur preparation et leur application en therapeutique
CA2373855A1 (fr) Methode de traitement de troubles psychotiques
WO2004078719A1 (fr) Composes a base de derives d'indole et medicaments contenant lesdits composes en tant que principe actif
JP3004727B2 (ja) ドパミン作動性活性を有するベンゾイミダゾール誘導体
JP3883567B2 (ja) Ｎ置換アザビシクロヘプタン誘導体、例えば神経弛緩剤
CA2346896C (fr) 3-tetrahydropyridin-4-yl indoles pour le traitement des troubles psychotiques
CA2320120C (fr) Derives de benzisoxasole ayant une activite antagoniste du recepteur d4
CA2175498C (fr) Composes de phenylindole
AU707770B2 (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl- pyridinyl and pyrimidinylpiperazines
JPH07505649A (ja) ヘテロ芳香族５−ヒドロキシトリプタミンレセプターアゴニスト
TW589312B (en) Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression
HU192416B (en) Process for preparing indole derivatives and pharmaceutical compositions containing sucg compounds
US20040142933A1 (en) Oxindole substituted piperazine derivatives
JPH09202784A (ja) 薬学的化合物
JPS6334152B2 (fr)
Srinivas et al. Synthesis and preliminary pharmacological investigations of 1-(1, 2-dihydro-2-acenaphthylenyl) piperazine derivatives as potential atypical antipsychotic agents in mice
MXPA01003882A (es) 3-tetrahidropiridin-4-il indoles para el tratamiento de trastornos psicoticos
FR2773800A1 (fr) Derives de benzimidazole, leur procede de preparation et leur application en therapeutique
CN101072770A (zh) 对于多巴胺－d2受体和5－羟色胺再摄取位点具有联合亲和力的四氢吡啶－4－基吲哚

Legal Events

Date Code Title Description
FZDE Dead